Intelligent Bio Solutions (INBS) Net Margin Growth (3y) (2022 - 2025)

Intelligent Bio Solutions (INBS) Net Margin Growth (3y) (2022 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -388.00
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -1.00
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -315.00
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 1,692.00
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 2.00
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 1,018.00
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 399.00
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Intelligent Bio Solutions 12.67 Mn 11.47 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 34,832.00
Dec 31, 2024 157,689.00
Mar 31, 2024 880,253.00
Dec 31, 2023 43,881.00
Sep 30, 2023 162,091.00
Jun 30, 2023 6,260.00
Mar 31, 2023 585,792.00
Dec 31, 2022 23.16 Mn